bone neoplasm: A benign, intermediate, or malignant neoplasm involving the bone or articular cartilage.
Benign neoplasm: Short bones of lower limb
DOID EFO Endpoint Browser PheWeb
CD2_BENIGN_BONE_SHORT_LOWER
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
409 |
4. Check minimum number of eventsNone |
409 |
5. Include endpointsNone |
409 |
6. Filter based on genotype QC (FinnGen only) |
374 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D16
- Name in latin
- Neoplasma benignum ossium brevium membri inferioris
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Short bones of lower limb
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of bone and articular cartilage
- Benign neoplasms
- Neoplasms
- Any operation in hilmo
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3041 | 1554 | 1476 |
| Only index persons | 2761 | 1424 | 1337 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.04 |
| Only index persons | 0.05 | 0.05 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 30.95 | 34.28 | 27.27 |
| Only index persons | 29.13 | 32.51 | 25.53 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 374 | 227 | 147 |
| Unadjusted period prevalence (%) | 0.08 | 0.08 | 0.07 |
| Median age at first event (years) | 35.65 | 32.92 | 39.85 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 381
- Matched controls
- 3810
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D16.3
ICD-10 Finland
Benign neoplasm: Short bones of lower limb
+∞
265.9
223
*
21307
ICD-8 Finland
Benign neoplasm of bone and cartilage, Ossium brevium extremitatis inferioris
+∞
102.9
94
*
2138A
ICD-9 Finland
Benign neoplasm of bone and articular cartilage, Short bones of lower limb
+∞
70.0
65
*
NHR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of ankle or foot
241.2
61.0
61
*
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
16.5
41.3
36
24
9102
FHL
Trepanation or removal of the local bone process
70.7
39.0
44
7
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
13.1
38.2
38
32
NHK10
NOMESCO Finland
Incision or excision of metatarsal or tarsal bone
19.5
19.4
29
16
D16.2
ICD-10 Finland
Benign neoplasm: Long bones of lower limb
31.9
18.6
24
8
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.7
17.7
62
189
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
6.2
12.7
22
37
NHR30
NOMESCO Finland
Complete excision of soft tissue tumour of ankle or foot
102.5
9.5
10
*
ZXA05
NOMESCO Finland
Left side
2.1
8.7
98
535
N02AX02
ATC
tramadol; systemic, rectal
1.9
8.6
176
1184
NHR99
NOMESCO Finland
Other operation for tumour of ankle or foot
92.0
8.4
9
*
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
8.7
7.9
16
19
WX320
NOMESCO Finland
Spinalanesthesy
2.0
7.7
102
589
9103
FHL
Partial or complete bone removal
25.6
7.6
10
*
9104
FHL
Autogenous bone graft
+∞
7.3
7
*
NH1DG
NOMESCO Finland
Ankle and foot very extensive MRI examination with high intensity magnet
+∞
7.3
7
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
6.8
175
1236
M20.1
ICD-10 Finland
Hallux valgus (acquired)
2.7
6.3
35
139
X58
ICD-10 Finland
Exposure to other specified factors
2.0
6.1
69
373
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
202
1594
1.57
4.48
2.9
2.8
—
—
estimate
—
0
0
6
5
12.16
3.77
10.7
2.8
77.67
38.80
u/l
—
6
5
282
2504
1.49
2.88
4.7
4.3
9.42
10.83
mm/h
1.44
269
2342
7
14
5.07
2.74
2.4
3.9
528.14
760.43
u/ml
—
7
14
7
19
3.73
2.16
1.4
1.2
8.43
15.63
u/l
—
7
19
13
55
2.41
2.14
1.3
1.2
—
—
—
0
0
13
55
2.41
2.14
1.3
1.2
—
—
—
0
0
24
134
1.84
2.00
1.7
2.0
—
—
—
0
0
7
21
3.38
1.97
1.6
3.6
68.43
159.76
nmol/l
—
7
21
284
2601
1.36
1.86
5.1
4.5
14.50
14.62
pmol/l
0.37
270
2391
36
234
1.59
1.78
1.5
1.6
—
—
—
0
0
345
3277
1.56
1.77
16.9
15.1
18.48
22.82
mg/l
2.09
288
2666
12
54
2.26
1.75
1.1
1.9
—
—
—
0
0
106
853
1.34
1.72
2.6
3.0
338.64
334.76
umol/l
0.17
98
760
163
1413
1.27
1.48
5.8
5.2
36.14
36.11
g/l
0.02
156
1333
359
3461
1.65
1.47
20.4
19.0
75.98
74.93
umol/l
0.20
359
3425
338
3220
1.44
1.46
4.8
4.8
1.46
1.47
mmol/l
0.11
321
3019
99
810
1.30
1.41
2.1
2.4
—
—
—
0
0
72
563
1.34
1.41
4.7
3.5
0.82
0.82
mmol/l
0.12
66
537
10
46
2.21
1.41
1.1
1.4
0.66
0.52
nmol/l
—
10
41
9
40
2.28
1.41
1.1
1.3
0.18
0.17
nmol/l
—
9
26
81
646
1.32
1.39
1.3
1.3
1.35
10.62
u/ml
4.63
38
254
320
3029
1.35
1.36
5.7
6.0
37.46
38.87
mmol/mol
3.12
306
2867
338
3230
1.41
1.33
5.0
4.9
4.67
4.66
mmol/l
0.10
324
3044
213
1929
1.24
1.25
5.1
5.4
6.30
6.56
mmol/l
1.05
207
1814
118
1005
1.25
1.21
4.2
4.0
0.00
0.02
estimate
0.96
39
357
6
26
2.33
1.19
1.3
1.3
675.00
705.93
u/l
—
6
26
23
150
1.57
1.17
1.8
2.5
35.17
39.94
u/l
0.55
23
140
161
1424
1.23
1.16
1.7
1.9
1.40
1.36
mmol/l
0.27
134
1220
201
1819
1.22
1.16
4.3
3.8
0.00
0.00
estimate
-0.00
42
378
29
201
1.48
1.13
1.1
1.0
—
—
—
0
0
271
2534
1.24
1.12
8.7
8.4
79.13
79.25
u/l
0.01
263
2404
157
1390
1.22
1.11
4.4
3.6
0.10
0.01
estimate
0.41
31
323
107
913
1.24
1.07
1.2
1.3
0.45
1.42
u/ml
2.98
28
269
28
196
1.46
1.05
3.0
2.7
25.37
45.96
u/ml
0.73
28
190
120
1039
1.23
1.05
3.8
3.1
0.00
0.00
estimate
0.50
32
305
130
1136
1.22
1.04
3.9
3.1
2.35
2.35
mmol/l
0.04
122
1039
11
60
1.86
1.04
3.2
1.3
13.37
3.30
ug/l
0.47
11
53
5
22
2.29
1.03
1.4
1.5
—
—
—
0
0
203
1853
1.20
1.03
4.4
3.9
0.00
0.01
estimate
0.50
42
354
68
553
1.28
1.02
3.5
3.1
0.76
0.77
ug/l
0.04
49
349
16
99
1.64
1.01
1.4
2.0
3.50
4.86
iu/l
—
6
40
85
712
1.25
1.00
1.4
1.3
10.78
28.48
iu/ml
4.76
25
212
5
23
2.19
0.98
1.2
1.4
—
—
—
0
0
42
322
1.34
0.96
3.7
3.2
—
—
—
0
0
339
3273
1.32
0.94
5.4
5.5
2.72
2.74
mmol/l
0.21
323
3067
6
27
2.24
0.94
1.0
1.2
—
—
—
0
0
124
1089
1.21
0.93
3.4
2.6
91.32
63.90
u/l
0.32
114
1013
200
1835
1.19
0.92
4.4
3.8
0.02
7.98
estimate
0.80
42
380
15
94
1.62
0.92
1.6
1.9
—
—
—
0
0
21
145
1.47
0.87
1.9
1.6
12.67
8.21
u/ml
—
7
34
159
1438
1.18
0.85
14.8
11.3
1.20
1.19
inr
0.16
125
1170
6
31
1.95
0.84
1.3
1.5
1.42
1.15
promille
—
6
25
327
3152
1.26
0.84
15.0
14.2
85.64
85.25
ml/min/173m2
0.13
307
2900
319
3067
1.25
0.84
6.1
5.4
1.68
1.85
mu/l
2.65
308
2864
8
46
1.75
0.83
1.0
1.0
—
—
—
0
0
13
81
1.63
0.82
1.4
1.3
—
—
—
0
0
86
740
1.21
0.80
4.6
4.4
20.48
21.60
%
0.34
44
353
37
288
1.32
0.79
1.2
1.3
184.18
125.81
u/ml
0.30
12
121
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
33
253
1.33
0.78
3.9
2.6
64.12
69.61
ml/min/173m2
0.38
17
108
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
91
1040
0.84
0.77
4.2
4.0
9.47
10.02
mg/mmol
0.03
55
644
6
34
1.78
0.76
1.0
1.0
—
—
—
0
0
9
54
1.68
0.75
1.2
1.2
—
—
—
0
0
9
56
1.62
0.73
4.0
3.3
24.11
32.01
u/ml
—
9
56
324
3134
1.23
0.71
5.0
4.8
5.67
5.86
mmol/l
3.20
311
2898
5
26
1.94
0.71
1.0
2.2
—
—
—
0
0
5
27
1.86
0.68
1.2
2.6
—
—
—
0
0
43
350
1.26
0.67
6.2
10.6
1.11
0.82
mmol/l
0.25
34
298
294
2824
1.18
0.67
19.5
19.2
331.30
332.46
g/l
0.46
294
2814
5
28
1.80
0.66
1.4
1.2
—
—
—
0
0
7
44
1.60
0.65
1.9
2.0
13.23
13.31
%
—
7
44
29
226
1.31
0.63
1.5
1.6
881.72
961.69
mu/l
0.31
24
195
23
173
1.35
0.63
1.9
1.9
1.36
5.23
iu/ml
—
8
39
25
191
1.33
0.62
1.2
1.4
—
—
—
0
0
13
187
0.68
0.62
2.0
1.7
—
—
—
0
0
8
51
1.58
0.61
1.0
1.1
1.27
1.50
g/l
—
8
46
12
80
1.52
0.60
1.4
1.2
—
—
—
0
0
10
64
1.58
0.59
4.1
2.3
14.53
7.62
pmol/l
—
10
64
27
211
1.30
0.59
2.7
3.0
4.95
5.04
kpa
0.26
27
201
317
3075
1.18
0.58
4.2
4.1
1.28
1.27
mmol/l
0.04
299
2869
5
86
0.58
0.57
1.2
1.5
—
—
—
0
0
190
1783
1.13
0.56
7.1
6.7
11.30
11.20
umol/l
0.03
179
1703
8
124
0.64
0.55
1.5
2.5
3.76
4.27
g/l
—
8
118
8
124
0.64
0.55
1.5
2.5
6.85
7.37
g/l
—
8
118
8
124
0.64
0.55
1.5
2.5
3.31
3.81
g/l
—
8
118
163
1518
1.13
0.54
2.6
2.5
79.06
74.83
nmol/l
1.02
154
1377
6
39
1.55
0.53
1.2
1.3
—
—
—
0
0
6
39
1.55
0.53
1.2
1.5
—
—
—
0
0
12
83
1.46
0.52
1.2
1.1
0.23
3.01
u/ml
—
7
49
6
40
1.51
0.52
1.2
1.3
—
—
—
0
0
171
1604
1.12
0.49
8.0
7.6
1.21
1.21
mmol/l
0.22
153
1381
16
119
1.36
0.49
1.4
1.5
—
—
—
0
0
7
46
1.53
0.48
1.3
1.3
—
—
—
0
0
16
120
1.35
0.47
1.5
1.5
0.89
0.96
ratio
0.76
11
77
16
120
1.35
0.47
1.5
1.5
1.40
1.13
ratio
0.62
11
77
16
120
1.35
0.47
1.5
1.5
1.49
1.20
ratio
0.49
11
77
8
117
0.68
0.46
1.5
2.6
2.61
2.99
g/l
—
8
111
7
49
1.44
0.46
1.1
1.2
—
—
—
0
0
5
85
0.58
0.46
1.6
1.7
—
—
—
0
0
17
131
1.31
0.43
1.9
1.5
—
—
—
0
0
90
820
1.13
0.42
4.6
3.8
1.02
1.02
kg/l
0.00
64
542
13
96
1.37
0.42
1.2
1.2
—
—
—
0
0
10
70
1.44
0.42
1.2
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
5
35
1.43
0.39
1.2
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
3.1
—
1.16
—
0
19
0
19
0.00
0.39
0.0
1.9
—
—
—
0
0
0
19
0.00
0.39
0.0
1.9
—
—
—
0
0
71
642
1.13
0.38
2.8
2.5
2.44
2.44
mmol/l
0.07
63
569
6
41
1.47
0.36
1.2
1.2
—
—
—
0
0
6
41
1.47
0.36
1.2
1.2
—
—
—
0
0
6
41
1.47
0.36
1.2
12.4
10.08
6.76
mmol/l
—
6
36
245
2368
1.10
0.36
3.7
3.4
43.69
45.38
u/l
0.15
235
2249
6
43
1.40
0.35
1.2
1.4
—
—
—
0
0
41
359
1.16
0.35
3.2
2.1
324.27
392.03
nmol/l
2.47
41
340
6
44
1.37
0.34
1.2
1.2
—
—
—
0
0
103
958
1.10
0.34
3.2
2.9
0.60
0.42
e6/l
0.27
74
684
59
532
1.13
0.34
2.6
2.3
—
—
—
0
0
202
1940
1.09
0.33
9.1
10.1
4.08
4.08
e9/l
0.01
178
1695
94
872
1.10
0.33
2.5
2.1
2.78
2.91
mg/l
0.14
84
754
102
951
1.10
0.32
1.7
1.7
20.76
21.01
nmol/l
0.06
93
810
288
2814
1.10
0.30
20.3
18.9
13.43
13.55
%
1.03
288
2787
13
102
1.28
0.30
1.2
1.2
—
—
—
0
0
13
102
1.28
0.30
1.2
1.2
—
—
—
0
0
31
269
1.17
0.30
3.7
2.1
—
—
—
0
0
152
1448
1.08
0.30
6.8
6.9
1.21
1.21
mmol/l
0.04
142
1340
10
76
1.32
0.28
1.6
1.3
127.40
162.02
au/ml
—
5
23
12
150
0.79
0.27
5.4
3.5
25.25
24.88
mmol/l
0.23
12
144
150
1433
1.08
0.27
2.1
2.0
97.92
95.54
pmol/l
0.23
79
740
82
765
1.09
0.26
1.9
1.7
—
—
—
0
0
5
72
0.69
0.26
1.2
1.6
—
—
—
0
0
5
72
0.69
0.26
1.2
1.5
—
—
—
0
0
107
1129
0.93
0.25
4.6
3.3
7.72
8.01
mmol/l
0.25
93
962
9
77
1.17
0.24
1.6
1.2
3.39
3.64
mmol/l
—
9
71
96
907
1.08
0.23
3.2
3.2
1312.62
994.31
ng/l
0.36
83
753
28
247
1.14
0.23
5.7
3.0
64.49
67.40
g/l
0.84
28
229
12
97
1.24
0.23
1.7
1.4
57.58
229.92
pmol/l
0.84
12
92
5
39
1.29
0.23
3.4
3.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
2.6
—
—
—
0
0
0
12
0.00
0.21
0.0
2.6
—
—
—
0
0
84
793
1.08
0.21
1.6
1.8
0.82
1.21
mg/l
1.36
59
619
0
13
0.00
0.21
0.0
1.2
—
407.00
—
0
7
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
102.38
—
0
8
0
13
0.00
0.21
0.0
2.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
4.2
—
4.58
—
0
13
0
13
0.00
0.21
0.0
4.2
—
10.94
—
0
13
53
491
1.09
0.20
2.5
2.1
—
—
—
0
0
66
618
1.08
0.20
5.3
3.8
1010.37
312.64
ng/l
0.61
49
451
0
14
0.00
0.20
0.0
1.1
—
118.00
—
0
9
36
327
1.11
0.20
2.4
2.5
27.29
30.78
u/l
0.71
28
273
6
49
1.23
0.20
1.2
1.5
—
—
—
0
0
6
51
1.18
0.19
1.2
1.3
—
—
—
0
0
13
109
1.20
0.19
2.6
2.7
—
—
—
0
0
36
329
1.10
0.18
3.8
2.1
—
—
—
0
0
19
166
1.15
0.18
1.5
1.3
—
—
—
0
0
16
139
1.16
0.16
1.3
1.3
—
—
—
0
0
21
187
1.13
0.16
1.2
1.5
0.26
0.36
mg/l
—
8
79
10
83
1.21
0.15
1.6
1.3
—
—
—
0
0
9
81
1.11
0.15
1.4
1.6
48.27
49.41
ug/l
—
9
81
13
150
0.86
0.15
1.1
1.4
362.60
299.66
miu/ml
—
5
81
12
103
1.17
0.14
2.2
1.2
—
—
—
0
0
8
98
0.81
0.14
1.1
1.8
—
—
—
0
0
48
509
0.93
0.13
1.6
1.7
1583.91
1194.21
nmol/l
1.36
35
390
9
110
0.81
0.13
1.7
1.7
—
—
—
0
0
57
542
1.06
0.12
1.9
2.0
—
—
—
0
0
10
85
1.18
0.12
1.7
1.2
—
—
—
0
0
10
85
1.18
0.12
1.0
1.5
—
—
—
0
0
30
278
1.09
0.12
1.4
1.4
—
—
—
0
0
31
288
1.08
0.12
1.5
1.7
3.71
3.49
mmol/l
0.64
19
211
119
1224
0.96
0.12
3.9
3.7
18.62
36.88
ng/l
3.06
73
820
37
347
1.07
0.12
5.8
6.5
—
—
—
0
0
15
134
1.12
0.11
2.3
1.6
—
—
—
0
0
35
329
1.07
0.10
3.8
4.3
6.63
40.79
ug/l
0.78
26
271
19
173
1.10
0.10
3.1
3.2
0.39
1.48
mmol/l
0.76
12
119
13
146
0.89
0.10
1.8
2.0
1.44
2.96
mg/l
—
7
103
43
408
1.06
0.10
1.8
1.9
—
—
—
0
0
56
536
1.05
0.10
3.0
2.9
8.83
2.53
e6/l
1.08
24
251
230
2269
1.03
0.10
3.2
3.4
—
—
—
0
0
6
57
1.05
0.08
1.2
1.9
—
—
—
0
0
41
391
1.05
0.08
1.8
1.9
3.58
3.46
ratio
0.28
30
309
5
60
0.83
0.08
1.0
1.3
—
231.43
—
0
7
5
60
0.83
0.08
1.0
1.3
—
—
—
0
0
5
62
0.80
0.08
1.2
4.1
44.18
467.26
u/ml
—
5
57
17
184
0.92
0.07
4.2
2.6
0.75
0.60
%
1.27
17
184
37
386
0.95
0.06
4.4
4.5
30.48
31.55
%
0.26
27
259
20
213
0.94
0.06
5.8
7.7
25.03
24.66
mmol/l
0.16
20
213
19
178
1.07
0.06
2.3
2.3
464.50
5109.47
u/l
—
8
67
14
150
0.93
0.04
1.4
1.5
—
—
—
0
0
47
459
1.03
0.03
8.0
7.4
104.96
104.20
mmol/l
0.47
47
459
12
112
1.07
0.03
4.1
3.3
1.65
1.43
mg/l
0.38
12
100
60
609
0.98
0.02
1.9
1.5
—
—
—
0
0
12
113
1.06
0.02
2.1
2.1
—
—
—
0
0
12
113
1.06
0.02
1.2
1.3
—
—
—
0
0
12
127
0.94
0.01
2.2
2.1
1.04
3.53
ug/l
0.56
12
116
66
652
1.01
0.01
1.7
1.7
400.23
32975344.35
pmol/l
0.76
56
558
11
104
1.06
0.01
1.5
1.3
227.20
294.04
ug/g
—
5
59
13
136
0.95
0.00
1.6
1.4
—
—
—
0
0
26
262
0.99
0.00
7.8
4.0
1.22
1.23
mmol/l
0.08
21
227
39
388
1.01
0.00
1.7
1.9
—
—
—
0
0
59
587
1.01
0.00
2.9
2.7
1.48
0.89
e6/l
0.44
28
299
11
106
1.04
0.00
2.1
1.9
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
9
91
0.99
-0.00
1.2
1.7
—
—
—
0
0
6
59
1.02
-0.00
1.8
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_BONE_SHORT_LOWER and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_BONE_SHORT_LOWER.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_BONE_SHORT_LOWER – Benign neoplasm: Short bones of lower limb
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data